GET CERTIFIED IN DRUG SAFETY


RECOGNIZED COURSE QUALITY


DESIGNED FOR EXPERTS BY EXPERTS


COMMUNICATING EMERGING SAFETY RISKS OF MARKETED MEDICINES


OBJECTIVES

This course aims to provide you knowledge and understanding of the challenges met by regulatory agencies in risk communication.

Risk communication, DHCP, pattern of drug, medicines

 

LEARNING OUTCOMES

At the end of the course, you will be able to:

  • review the impact of existing means risk communication

  • understand how the impact of DHCP on patterns of drug use can be evaluated and the potential determinates (both DHCP & drug) of that impact

 

120 minutes
Online based learning
English language
Certificate of Achievement
500 €
BOOK NOW

AUTHOR

avatar

Dr. Peter Mol

Principal Assessor of Pharmacotherapy Group II; cardiovascular, diabetes and female hormone products
Dutch Medicines evaluation Board



COMPANIES OFFER

Short courses can be included in a training package for your team!


NEED TO TALK TO US?

+33 5 47 30 42 69

Monday-Friday / 9.00am-6.00pm CET

 

Supported By

IMI logo EU logo efpia logo

Created By

Eu2P Partners